Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis

Table 3 Relationship between GlycA and cardiovascular disease^a

GlycA	OR (95 % CI)	P-value	OR^b (95 % CI)	Adjusted P-value^b	OR^c (95 % CI)	Adjusted P-value^c	OR^d (95 % CI)	Adjusted P-value^d
Coronary calcium	1.32 (0.99, 1.74)	0.06	1.48 (1.04, 2.11)	0.03	1.39 (0.97, 2.01)	0.07	1.35 (0.93, 1.95)	0.12
Known CAD	1.83 (1.10, 3.03)	0.02	2.10 (1.17, 3.77)	0.01	2.14 (1.17, 3.92)	0.01	2.10 (1.13, 3.88)	0.02

^aAll analyses were performed using logistic regression. CAD, Coronary artery disease; CI, Confidence interval; OR, Odds ratio per quartile increase in GlycA concentration. ^bAdjusted for age, race and sex. ^cAdjusted for age, sex, total cholesterol, high-density lipoprotein (HDL) cholesterol, smoking status, systolic blood pressure and anti-hypertensive use. ^dAdjusted for age, sex, total cholesterol, HDL cholesterol, smoking status, systolic blood pressure, anti-hypertensive use and diabetes

ISSN: 1478-6362